Intervention Strategy for Depression and Obesity in Beijing Adolescents
This study aims to prevent depression and obesity in teenagers living in Beijing by using a specific intervention strategy and measuring its impact with a health questionnaire.
combination intervention strategy of [Comorbidity-Co-causes-Joint-prevention]
+ routine health education and mental health knowledge
Behavior+8
+ Behavioral Symptoms
+ Body Weight
Prevention Study
Summary
Study start date: August 1, 2024
Actual date on which the first participant was enrolled.This study is focused on finding better ways to prevent and manage depression and obesity among children and adolescents in Beijing. Both depression and obesity are common in young people, often occurring together and sharing similar causes, which can have significant impacts on their health and well-being. The study aims to develop a new prevention method called "Comorbidity-Co-causes-Joint-prevention", which combines different strategies to address these issues jointly. This approach is important because it seeks to create a sustainable and effective way to tackle these health problems, potentially reducing their burden on individuals and society. Participants in the study will be part of a program that uses a digital platform to deliver the intervention, aiming to ensure it is accessible and easy to use. The study will assess how well this intervention works across different groups and organizations, looking at factors like the reach and sustainability of the program. The effectiveness of the intervention will be measured using the RE-AIM framework, which evaluates its reach, effectiveness, adoption, implementation, and maintenance. The findings will help establish a model for preventing depression and obesity in young people, aligning with broader health goals for Beijing and China.
Protocol
This section provides details of the study plan, including how the study is designed and what the study is measuring.440 patients to be enrolled
Total number of participants that the clinical trial aims to recruit.Prevention Study
Eligibility
Researchers look for people who fit a certain description, called eligibility criteria: person's general health condition or prior treatments.Any sex
Biological sex of participants that are eligible to enroll.Healthy volunteers not allowed
If individuals who are healthy and do not have the condition being studied can participate.Conditions
Pathology
Criteria
Inclusion Criteria: * Stage I (screening stage): 1. Middle school students in Beijing Economic-Technological Development Area and other districts of Beijing, both male and female; 2. Students themselves and their guardians are willing to participate in this study and sign written informed consent file. Stage Ⅱ: Middle school students who were identified as high risk of depression and/or obesity in Stage I in Beijing Economic-Technological Development Area and other districts of Beijing, the screening criteria are as follows: ① CES-DC score ≥16 points; ② BMI ≥WS/T586-2018: Screened as overweight and obesity among school-age children and adolescents, according to the recommendation by the National Health Commission; ③ Students themselves and their guardians are willing to participate in this study and provide written informed consent. Exclusion Criteria: * Stage I: 1. Having serious physical or genetic disease that is not suitable for participation in the study; 2. Have been evaluated that not suitable for this study by investigators. Stage Ⅱ: 1. Having serious physical or genetic disease that is not suitable for participation in the study; 2. Have been evaluated that not suitable for this study by investigators.
Study Plan
Find out more about all the medication administered in this study, their detailed description and what they involve.2 intervention groups are designated in this study
50% chance of being blinded to the placebo group
Treatment Groups
Group I
Active ComparatorGroup II
PlaceboStudy Objectives
Primary Objectives
Secondary Objectives
Study Centers
These are the hospitals, clinics, or research facilities where the trial is being conducted. You can find the location closest to you and its status.This study has 1 location
Beijing Anding Hospital, Capital Medical University
Beijing, ChinaOpen Beijing Anding Hospital, Capital Medical University in Google Maps